Large Or Small Molecule: Drug Sponsors Share API Outsourcing Philosophy

Chief Editor Louis Garguilo at Outsourced Pharma asks “Are there strategic and tactical differences for [Large or Small Molecule] programs when outsourcing to CMOs?”   In the small molecule report (SMR), 70% of biopharma companies that use “preferred provider lists” responded that 1 to 5 CMOs make up that list; 20% said it was between … Continued